Dr Jaskanwal Singh Bisla, MD | |
1955 W Frye Rd, Chandler, AZ 85224-6282 | |
(480) 428-5500 | |
Not Available |
Full Name | Dr Jaskanwal Singh Bisla |
---|---|
Gender | Male |
Speciality | Cardiac Electrophysiology |
Experience | 14 Years |
Location | 1955 W Frye Rd, Chandler, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003127457 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0001X | Internal Medicine - Clinical Cardiac Electrophysiology | 47484 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Chandler Regional Medical Center | Chandler, AZ | Hospital |
Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sjhmc Physician Services | 4486646197 | 533 |
News Archive
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that it has acquired Catalyst Information Technologies, Inc., d/b/a Catalyst Technologies, a leader in healthcare clinical quality outcomes analysis and data analytical toolset development.
Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.
UT Southwestern Medical Center researchers, in conjunction with NASA, will take four volunteer cancer patients on a zero-gravity ride into the upper atmosphere to study why zero-gravity conditions on the International Space Station sometimes affect the vision of astronauts staying there for extended periods.
› Verified 4 days ago
Entity Name | Tri-city Cardiology Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144288416 PECOS PAC ID: 2062303076 Enrollment ID: O20040322000116 |
News Archive
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that it has acquired Catalyst Information Technologies, Inc., d/b/a Catalyst Technologies, a leader in healthcare clinical quality outcomes analysis and data analytical toolset development.
Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.
UT Southwestern Medical Center researchers, in conjunction with NASA, will take four volunteer cancer patients on a zero-gravity ride into the upper atmosphere to study why zero-gravity conditions on the International Space Station sometimes affect the vision of astronauts staying there for extended periods.
› Verified 4 days ago
Entity Name | Sjhmc Physician Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that it has acquired Catalyst Information Technologies, Inc., d/b/a Catalyst Technologies, a leader in healthcare clinical quality outcomes analysis and data analytical toolset development.
Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.
UT Southwestern Medical Center researchers, in conjunction with NASA, will take four volunteer cancer patients on a zero-gravity ride into the upper atmosphere to study why zero-gravity conditions on the International Space Station sometimes affect the vision of astronauts staying there for extended periods.
› Verified 4 days ago
Entity Name | Northwest Allied Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003833179 PECOS PAC ID: 7618972514 Enrollment ID: O20060928000110 |
News Archive
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that it has acquired Catalyst Information Technologies, Inc., d/b/a Catalyst Technologies, a leader in healthcare clinical quality outcomes analysis and data analytical toolset development.
Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.
UT Southwestern Medical Center researchers, in conjunction with NASA, will take four volunteer cancer patients on a zero-gravity ride into the upper atmosphere to study why zero-gravity conditions on the International Space Station sometimes affect the vision of astronauts staying there for extended periods.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jaskanwal Singh Bisla, MD 3200 S Alma School Rd Ste 204, Chandler, AZ 85248-3773 Ph: (480) 728-5500 | Dr Jaskanwal Singh Bisla, MD 1955 W Frye Rd, Chandler, AZ 85224-6282 Ph: (480) 428-5500 |
News Archive
Scientists are reporting a discovery of the potential basis for a urine test to diagnose community-acquired pneumonia (CAP), a difficult-to-diagnose disease that is the sixth leading cause of death in the United States.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that it has acquired Catalyst Information Technologies, Inc., d/b/a Catalyst Technologies, a leader in healthcare clinical quality outcomes analysis and data analytical toolset development.
Tumor necrosis factor inhibitor drugs (commonly called Anti-TNFs) modestly reduce the risk of acute coronary syndrome, such as heart attacks and angina, in rheumatoid arthritis patients whose inflammation places them at higher risk of developing coronary heart disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Diego.
A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research.
UT Southwestern Medical Center researchers, in conjunction with NASA, will take four volunteer cancer patients on a zero-gravity ride into the upper atmosphere to study why zero-gravity conditions on the International Space Station sometimes affect the vision of astronauts staying there for extended periods.
› Verified 4 days ago
Dr. Naga Nalini Tirumalasetty, MD,ECNU,FACE. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 908 W Chandler Blvd Ste 4, Chandler, AZ 85225 Phone: 480-269-6448 Fax: 779-204-2331 | |
Amer Al-khoudari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 604 W Warner Rd Ste C1, Chandler, AZ 85225 Phone: 480-372-8200 Fax: 480-372-8222 | |
Bidya Lohani-sharma, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 845 E Warner Rd Ste 101, Chandler, AZ 85225 Phone: 480-786-5000 Fax: 480-786-5050 | |
Nisar Ahmed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Chuck Stephen Mangubat, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Dr. Edward Markman, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 S Dobson Rd, Chandler, AZ 85224 Phone: 480-926-0170 |